PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025C00024DIRECT to PHASE II SBIR concept — Continuity Biosciences, LLC

Continuity Biosciences, LLC holds $3.0M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 16 offers. Set-aside status: SBA. Recompete timing centers on the Sep 4, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Continuity Biosciences, LLC

Recipient

Sep 4, 2027

PoP end

$3M

Obligated

$3M

Potential

541715

NAICS

AN12

PSC

SBA

Set-aside

16 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Continuity Biosciences, LLC — $90

Contract facts

SBA

Contract number75N91025C00024

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentContinuity Biosciences, LLC

CAGE13F55

UEIKTR8EE8DBFX5

NAICS541715

PSCAN12

Place of performanceCARY NC

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startSep 5, 2025

PoP end (current)Sep 4, 2027

Obligated$3M

Current value$3M

Potential value$3M

DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCER is a federal SBA award for Nih Nci held by Continuity Biosciences, LLC. Estimated value $3M ($3M obligated). Current period of performance ends Sep 4, 2027. Last award drew 16 bidders. Place of performance: CARY NC.

DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCER

Recompete timing

Public

● Expiring in 362 days

Current PoP ends Sep 4, 2027 (362 days remaining). Agencies typically plan 12–18 months ahead — at 11.9 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Continuity Biosciences, LLC — $3.0M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$3.0M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91025C00024?

75N91025C00024 (DIRECT to PHASE II SBIR concept) is a Nih Nci award with a potential value of $3M, currently held by Continuity Biosciences, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025C00024?

Nih Nci awarded 75N91025C00024 to Continuity Biosciences, LLC (potential $3M).

Who is the incumbent on 75N91025C00024?

Continuity Biosciences, LLC is the incumbent with $3.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 4, 2027.

When does Continuity Biosciences, LLC’s 75N91025C00024 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 4, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91025C00024 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action May 14, 2026